Trump Questions Housing Bill as He Prioritizes SAVE America Act 
Lenovo Shares Slide as AI-Driven Memory Demand Signals Higher DRAM and NAND Prices 
Baidu Shares Rally as Kunlunxin Eyes $50 Billion Hong Kong IPO 
SoftBank Shares Slide as OpenAI IPO Delay Concerns Weigh on AI Investment Outlook 
Canada Grants C$7 Million to Greenland Molybdenum Mine to Strengthen Critical Minerals Supply 
Gold Price Drops to Eight-Month Low as Fed Rate Hike Bets Weigh on Bullion. Source: Photo by Michael Steinberg via Pexels 
Oil Prices Slip as U.S.-Iran Peace Talks and Strait of Hormuz Risks Keep Markets on Edge 
South Korea Alleges Google Abused Android App Store Dominance, Eyes Major Fine 
Buffett Delays Gates Foundation Donation Pending Epstein Ties Review 
RBA Minutes Signal Australia Central Bank Remains Ready to Raise Interest Rates if Inflation Persists 
Microsoft Reportedly Plans New Job Cuts Across Sales, Consulting, and Xbox 
Anthropic Brings Claude AI Models to Microsoft Azure Foundry With NVIDIA Blackwell GPUs 
Anthropic Restores Claude Fable 5 and Mythos 5 After U.S. Lifts AI Export Controls 
Baige Online Shares Soar 333% in Hong Kong IPO Debut as AI Insurance Demand Lifts Chinese Listings 
Michael Burry Shorts Tesla at $416 as AI and Semiconductor Bearish Bets Expand 
Trump Suspends Some Morocco Fertilizer Tariffs to Ease U.S. Supply Shortage 
Open-Source AI Models Gain Ground as Enterprises Seek Lower-Cost Alternatives, Citi Says 
Korea Ginseng Corporation inaugurated its research and development (R&D) center in California. The leading South Korean ginseng producer said on Wednesday, March 15, that it has set up a facility in the United States to expand its presence in the American market while also boosting its sales overseas.
Korea Ginseng Corp. is the maker of the no. 1 ginseng brand in the world known as CheongKwanJang. The opening of its R&D center in the U.S. is a major step toward increasing its market share in the region. Moreover, the center was built so the company can continue developing Korean ginseng into a product that will suit the preference of Americans.
As per The Korea Herald, the ginseng products manufacturer said that with its new R&D center, it would conduct research to find ways of enhancing and broadening the use of its flagship red ginseng products currently being sold in the U.S.
The company especially wants to bolster its products' capability of improving customers' immunity and memory and reducing fatigue. Aside from product development, the center will also serve as a hub that will manage the manufacturing process and quality control of the health products that will be made there.
Korea Ginseng Corp. mentioned its R&D in California will further function as an office for its business ventures in neighboring foreign markets, including Central and South America. The facility will collect data about health drinks and food markets so the company can improve its products based on the information.
"Our US R&D Center will contribute to the construction of local production infrastructure while strengthening the development of customized ginseng products for local consumers," KGC's chief executive officer, Heo Chul Ho, said during the R&D center's inauguration. "The U.S. R&D center will contribute to building infrastructure for a localized manufacturing line as well as strengthening development for localized products."
In a separate press release, the CEO of KGC US, Heung Sil Lee, further said, "This will be a momentous year for our global business. As we meet the unique needs of our U.S. customers by actively developing products specifically tailored to their lifestyles."
